These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27011240)

  • 1. [The netrin-1 cue regulates somatic cell reprogramming to pluripotency].
    Mehlen P; Lavial F
    Med Sci (Paris); 2016 Mar; 32(3):241-4. PubMed ID: 27011240
    [No Abstract]   [Full Text] [Related]  

  • 2. Concise review: dedifferentiation meets cancer development: proof of concept for epigenetic cancer.
    Yamada Y; Haga H; Yamada Y
    Stem Cells Transl Med; 2014 Oct; 3(10):1182-7. PubMed ID: 25122691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Netrin-1 regulates somatic cell reprogramming and pluripotency maintenance.
    Ozmadenci D; Féraud O; Markossian S; Kress E; Ducarouge B; Gibert B; Ge J; Durand I; Gadot N; Plateroti M; Bennaceur-Griscelli A; Scoazec JY; Gil J; Deng H; Bernet A; Mehlen P; Lavial F
    Nat Commun; 2015 Jul; 6():7398. PubMed ID: 26154507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming of Notch1-induced acute lymphoblastic leukemia cells into pluripotent stem cells in mice.
    Zhang H; Cheng H; Wang Y; Zheng Y; Liu Y; Liu K; Xu J; Hao S; Yuan W; Zhao T; Cheng T
    Blood Cancer J; 2016 Jul; 6(7):e444. PubMed ID: 27391576
    [No Abstract]   [Full Text] [Related]  

  • 5. Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.
    Knappe N; Novak D; Weina K; Bernhardt M; Reith M; Larribere L; Hölzel M; Tüting T; Gebhardt C; Umansky V; Utikal J
    Stem Cells; 2016 Apr; 34(4):832-46. PubMed ID: 26753613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells : it looks simple but can looks deceive?
    Lako M; Armstrong L; Stojkovic M
    Stem Cells; 2010 May; 28(5):845-50. PubMed ID: 20235273
    [No Abstract]   [Full Text] [Related]  

  • 7. p53 connects tumorigenesis and reprogramming to pluripotency.
    Tapia N; Schöler HR
    J Exp Med; 2010 Sep; 207(10):2045-8. PubMed ID: 20876313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency.
    Ferreirós A; Pedrosa P; Da Silva-Álvarez S; Triana-Martínez F; Vilas JM; Picallos-Rabina P; González P; Gómez M; Li H; García-Caballero T; González-Barcia M; Vidal A; Collado M
    Stem Cell Reports; 2019 May; 12(5):1099-1112. PubMed ID: 31056476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Back to basics: Refined nuclear reprogramming techniques yield higher-quality stem cells.
    Buganim Y
    Science; 2016 Jun; 352(6292):1401. PubMed ID: 27313030
    [No Abstract]   [Full Text] [Related]  

  • 10. Netrin-1 signaling mediates NO-induced glial precursor migration and accumulation.
    Chen H; Wei Q; Zhang J; Xu C; Tan T; Ji W
    Cell Res; 2010 Feb; 20(2):238-41. PubMed ID: 20084084
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic modification-free reprogramming to induced pluripotent cells: fantasy or reality?
    Tada T
    Cell Stem Cell; 2008 Aug; 3(2):121-2. PubMed ID: 18682230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iPS cells: potent stuff.
    Baker M
    Nat Methods; 2010 Jan; 7(1):17-9. PubMed ID: 20050392
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of pluripotency genes by a nanotube-mediated protein delivery system.
    Cho SJ; Choi HW; Cho J; Jung S; Seo HG; Do JT
    Mol Reprod Dev; 2013 Dec; 80(12):1000-8. PubMed ID: 24038603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell reprogramming. Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming.
    Gonzalez-Muñoz E; Arboleda-Estudillo Y; Otu HH; Cibelli JB
    Science; 2014 Aug; 345(6198):822-5. PubMed ID: 25035411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cell technology for dissecting the cancer epigenome.
    Semi K; Yamada Y
    Cancer Sci; 2015 Oct; 106(10):1251-6. PubMed ID: 26224327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A developmental framework for induced pluripotency.
    Takahashi K; Yamanaka S
    Development; 2015 Oct; 142(19):3274-85. PubMed ID: 26443632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-based system in stem cell reprogramming; differentiation/dedifferentiation.
    Pourrajab F; Babaei Zarch M; BaghiYazdi M; Hekmatimoghaddam S; Zare-Khormizi MR
    Int J Biochem Cell Biol; 2014 Oct; 55():318-28. PubMed ID: 25150833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Long Non-coding RNAs in Reprogramming to Induced Pluripotency.
    Kanwal S; Guo X; Ward C; Volpe G; Qin B; Esteban MA; Bao X
    Genomics Proteomics Bioinformatics; 2020 Feb; 18(1):16-25. PubMed ID: 32445708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New windows to enhance direct reprogramming of somatic cells towards induced pluripotent stem cells.
    Nakhaei-Rad S; Bahrami AR; Mirahmadi M; Matin MM
    Biochem Cell Biol; 2012 Apr; 90(2):115-23. PubMed ID: 22166043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.
    Olmez I; Shen W; McDonald H; Ozpolat B
    J Cell Mol Med; 2015 Jun; 19(6):1262-72. PubMed ID: 25787115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.